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Background: Although the levels of immunoglobulin
E (IgE) in the circulating blood are often elevated in
patients  with  allergic  diseases,  such  levels  cannot
always  be  considered  as  pathognomonic  signs  of
allergy.  The  induction  of  allergic  reactions  in  the
tissue was inferred to be related to the amount of IgE
passing through the vascular wall.
Aims:  We  attempted  to  clarify  which  compartment,
the intravascular or extravascular, plays an important
role in the regulation of the turnover of rat IgE.
Methods:  The  level  of  DNP-specific  rat  IgE  in  the
serum  was  estimated  by  IgE-capture  enzyme-linked
immunosorbent assay, and the turnover of IgE was
analyzed from its pharmacokinetic parameters.
Results: The transfer rate constants from the central
to tissue compartment  (Kct)  were larger than those
from the tissue to central compartment (Ktc) irrespec-
tive of the sensitized state. The value of the distribu-
tion volume of the tissue compartment (Vt) was larger
than  that  of  the  distribution  volume  of  the  central
compartment  (Vc)  irrespective  of  the  sensitized
state.
Conclusions:  These  findings  suggest  that  the  short
half-life of rat IgE in the circulation could be attribut-
able to the distribution of IgE from the intravascular
to the extravascular compartment.
Key words: Rodent, Allergy, Antibodies,  IgE  turnover, In
vivo animal models
Introduction
The levels of immunoglobulin E (IgE) in the circulat-
ing blood are often elevated in patients with allergic
diseases. However, such levels cannot be considered
as pathognomonic signs of allergy. Our previous data
have suggested that airway responses in Wistar rats
appeared more easily when the IgE levels decreased
than when they increased.1 The induction of allergic
reactions in the tissue was inferred therefore to be
related to the amount of IgE, which passes through
the  vascular  wall,  the  catabolism  of  IgE  in  the
extravascular  compartment  and/or  cellular  condi-
tions,  i.e.  the  number,  heterogeneity  and  develop-
ment of mast cells. It is thus important to investigate
the  turnover  of  IgE  in  the  circulating  blood  when
attempting  to  clarify  the  mechanisms  of  allergic
reactions occurring in the tissue. On the contrary, IgE
is known to exhibit the highest fractional catabolic
rate, and a half-life of 24–48h in humans as compared
with 10–14 days for IgG.2–4 The hypothesis has been
put forward that an increased catabolic rate of IgE is
dependent on the existence of intravascular and/or
extravascular  compartments  capable  of  specifically
clearing  the  IgE.4 Human  IgE  is  reported  to  be
metabolized mainly in the extravascular compartment
and the catabolism of IgE is related to the interaction
of IgE with Fc« receptor-bearing cells.2–4 In contrast,
it has also been speculated that the vascular endothe-
lium represents a site of catabolism of IgE based on
experiments  that  indicated  catabolism  is  a  diffuse
process not dependent on any one organ.4 Rat IgE has
been reported by Tada et al.5 to have an extremely
short half-life (approximately 12h) in the circulation.
However, the turnover of IgE in the circulating blood
and patterns of distribution of IgE in the rat have not
been  investigated  by  analyzing  the  metabolic  para-
meters  of  IgE.  In  the  present  study,  we  examined
which  compartment,  the  intravascular  or  extrava-
scular, plays an important role in the regulation of the
turnover of IgE in rats.
Materials and methods
Animals
Wistar strain male rats weighing  250–300g (Kyudo
Co., Ltd., Kumamoto, Japan) were employed in the
experiments. Ten Wistar rats were divided into two
groups,  each  consisting  of  five  rats.  Group A  was
untreated, and group B was sensitized with ovalbumin
(OVA). One milligram of OVA suspended in 0.5ml of
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(1010 cells)  according  to  the  method  of Tada  and
Okumura.6 This  mixture  was  divided  into  aliquots
(four solutions) and injected subcutaneously into the
footpads of the rats to be sensitized. At 5 days after the
first sensitization, the rats were boosted with 0.5mg
of OVA suspended in 0.25ml of physiological saline.
Cannulation  of  the  jugular  vein  was  performed
according  to  the  method  of  Nakasone  et  al.7 The
cannulation of the animals for the administration of
IgE and blood sampling was carried out at day 6 after
the  first  sensitization.  Estimations  of  the  passive
cutaneous anaphylaxis (PCA) titers in the serum of
rats sensitized with OVA were carried out according
to the method of Tada and Okumura.6
We followed the Standards Relating to the Care and
Management  of  Experimental Animals  (Notification
No. 6, 27 March 1980, Prime Minister’s Office, Tokyo,
Japan) for the care and use of the animals, together
with the guide for animal experiments issued by the
University  of  the  Ryukyus. All  animal  studies  were
reviewed and approved by the Animal Care Commit-
tee at the University of the Ryukyus.
Reagents
2,4-Dinitrobenzene  sulfonic  acid  sodium  salt  was
purchased from Tokyo Kasei Inc., Ltd. (Tokyo, Japan),
and  killed  B.  pertussis from  Kaken  Chemical  Ltd.
(Osaka,  Japan).  Chicken  egg  albumin  (OVA)  and
2,29 -azino-di-[3-ethyl-benzthiazoline-6-sulfonic  acid]
were purchased from Sigma Chemical Co. (St. Louis,
MO, USA). Tween 20 and gelatin fine powder were
obtained  from  Nacalai Tesque  (Kyoto,  Japan),  and
hydrogen  peroxide  from  Santoku  Chemical  Ind.
(Miyagi,  Japan).  Aminohexanoyl-biotin-N-hydroxy-
succinimide, peroxidase-conjugated streptavidin and
mouse anti-rat myeloma IgE (MARE-1) were obtained
from Zymed Laboratories (San Francisco, CA, USA).
Intramedic  polyethylene  tubing  (inner  diameter,
0.28mm;  outer  diameter,  0.61mm)  was  purchased
from Becton Dickinson and Company (Franklin Lakes,
NJ, USA). Unless otherwise stated, all other chemicals
were of reagent grade.
Preparation of monoclonal
dinitrophenyl-specific rat IgE
The  procedure  employed  for  the  preparation  of
monoclonal dinitrophenyl (DNP)-specific rat IgE was a
modification of that described previously.8 Cultured
medium from rat IgE-secreting hybridoma (FE-3) was
applied to a column of DNP-BSA-Sepharose 4B. The
adsorbed protein was eluted with 90 mM DNP-glycine
(pH 8.2). Free DNP-glycine was removed by dialysis
against  several  changes  of  Dulbecco’s  phosphate-
buffered saline. This procedure was repeated twice at
4°C, and a single band was observed at 200kDa on
sodium dodecyl sulfate-polyacrylamide gel electropho-
resis and Western blot analysis utilizing mouse anti-rat
myeloma IgE for the protein obtained.
Administration of monoclonal DNP-specific rat
IgE and blood sampling
Two milligrams  of  monoclonal DNP-specific rat IgE
was given  intravenously to  the  rats sensitized with
OVA at day 8 after the first sensitization and to the
normal  rats  via  the  jugular  vein  cannula.  Blood
samples of 0.5ml were taken from the jugular vein
cannula  and  an  identical  volume  of  physiological
saline was subsequently injected at 15min, and 1, 3,
6,  12  and 24h  after the  administration of IgE. The
serum was kept at –20°C until determination of its
IgE levels.
IgE-capture enzyme-linked immunosorbent
assay for estimation of monoclonal
DNP-specific rat IgE
The IgE-capture enzyme-linked immunosorbent assay
(ELISA) for estimating rat IgE antibodies to DNP-As
was performed as described previously.8
Calculation of pharmacokinetic parameters
Best-fit curves for the concentration of  monoclonal
DNP-specific rat IgE versus time were plotted by least-
squares linear regression analysis. The resultant curves
exhibited the biexponential pattern characteristics of
a two-compartment model. Semi-logarithmic plots of
the concentration of IgE were of the form Cc = Ae–a t
+  Be–b t,  where  Cc represents the  concentration of
monoclonal DNP-specific rat  IgE  in  the serum  at  a
given  time  (t),  A and  B denote  the  respective
intercepts of the initial and terminal phases, and the
coefficients  a and b were derived graphically from
the  slopes  of  the  biphasic  curves.  Compartment
models were fitted for serum concentration against
time  course  of  IgE,  and  the  pharmacokinetic para-
meters  were  then  calculated  from  the  values
obtained, as hybrid parameters (involving A, B, a and
b ). The apparent first-order intercompartmental rate
constants (Kct and Ktc), the tissue concentration of
IgE, the distribution volume of the central compart-
ment  (Vc)  and  tissue  compartment (Vt),  and other
pharmacokinetic parameters were derived from the
equations described by Rowland and Tozer.9
Statistical analysis
Statistical  analysis  was  performed  by  the  unpaired
Student’s t-test for between-group comparisons. Data
are expressed as the means ± standard deviation (SD).
When  a  p value  less  than  0.05  was  obtained,  the
means were considered to be significantly different.
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Changes of PCA titer following sensitization
with OVA
The  PCA  titer  in  the  serum  of  the  rats  sensitized
with OVA increased to its highest value between day
8 and day 10 (Fig. 1A). Monoclonal DNP-specific rat
IgE was therefore administered to the rats at day 8
after the first sensitization with OVA in subsequent
experiments.
Dose–response curve in IgE-capture ELISA for
monoclonal DNP-specific rat IgE
The absorbance level in the serum of OVA-sensitized
rats with IgE administration was correlated with the
dilution  of  the  serum.  However,  the  absorbance
level in the serum of OVA-sensitized rats without IgE
administration was not correlated with the dilution
of the serum (Fig. 1B). It was evident, therefore, that
DNP-specific  IgE  administered  to  rats  could  be
determined by  the  procedure of  IgE-capture  ELISA
employed.
Serum concentration-time curves for
monoclonal DNP-specific rat IgE in rats
following intravenous (i.v.) administration
The level of monoclonal DNP-specific rat IgE in the
serum underwent a rapid decrease between 15min
and 3h, and then declined slowly between 6 and 24h
following i.v. administration irrespective of the sensi-
tized state. The IgE levels at 15min–3h and at 6–24h,
respectively,  displayed  broadly  linear  decreases  on
semi-logarithmic  graphs  (Fig.  1C). The  turnover  of
monoclonal DNP-specific rat IgE administered to the
rats was therefore analyzed using a two-compartment
model for the pharmacokinetics.
Analysis of rat IgE turnover
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FIG. 1. (A) Changes in PCA titer following sensitization with OVA. Three Wistar rats were employed as recipients. Data are
expressed as means ± SD (n = 3). (B) Dose–response curve in IgE-capture ELISA for monoclonal DNP-specific rat IgE. Open
circles,  Serum of Wistar rats sensitized with OVA at day 8; closed circles,  serum of Wistar rats sensitized with OVA and
administered with  monoclonal  DNP-specific  rat  IgE  at  day  8.  The  serum  was  diluted  with  2%  gelatin-PBST (Dulbecco’s
phosphate-buffered saline containing 0.05% Tween 20). Data are expressed as means ± SD (n = 5). (C) Serum concentration-
time curves for monoclonal DNP-specific rat IgE in rats following i.v. administration. Two milligrams of monoclonal DNP-
specific rat IgE was administered to rats via the jugular vein. Open circles, Non-sensitized rats (group A); closed circles, OVA-
sensitized rats (group B). Data are expressed as means ± SD (n = 5). (D) Tissue concentration-time curves for monoclonal
DNP-specific rat IgE in rats following i.v. administration. Two milligrams of monoclonal DNP-specific rat IgE was administered
to rats via the jugular vein. Open circles, Non-sensitized rats (group A); closed circles, OVA-sensitized rats (group B). Data are
expressed as means ± SD (n = 5).Tissue concentration-time curves for
monoclonal DNP-specific rat IgE in rats
following i.v. administration
The tissue concentration of monoclonal DNP-specific
rat IgE was calculated, and found to increase to its
highest  value  at  between  1  and  3h  following  i.v.
administration to  the  rats  irrespective of  the  sensi-
tized state (Fig. 1D).
Pharmacokinetic parameters
No significant differences in distribution half-life (t1/2a )
were observed between the non-sensitized and OVA-
sensitized  rats.  The  elimination  half-life  (t1/2b )  of
monoclonal  DNP-specific  rat  IgE  was  about  12h
following i.v. administration to the rats irrespective of
the sensitized state.  The transfer rate constants from the
central to tissue compartment (Kct) were larger than
those from the tissue  to central compartment (Ktc)
irrespective of the sensitized state (p < 0.05). The value
of the distribution volume of the tissue compartment
(Vt) was larger than that of the distribution volume of
the  central  compartment  (Vc)  irrespective  of  the
sensitized state (group A, p < 0.05; group B, p < 0.01).
No significant difference was observed in the other
pharmacokinetic parameters,  including  the  elimina-
tion  rate  constant  (Kel),  the  area  under  the  serum
concentration-time  curve  (AUC)  and  the  total  body
clearance (CLtotal), in the present study (Table 1).
Discussion
The half-life  of  rat  IgE  in  the circulating  blood has
been reported by Tada et al.5 to be about 12h. In
the present study, the elimination half-life  (t1/2b ) of
monoclonal  DNP-specific  rat  IgE  was  found  to  be
about 12h following  i.v.  administration to rats irre-
spective  of  the  sensitized  state. These  results  are
clearly  consistent  with  each  other.  However,  the
aforementioned report5 did not describe the pattern
of distribution and elimination of IgE in the rats, or
the transfer rate of IgE between the circulation and
tissue,  since  no  investigations  were  made  of  the
turnover of IgE through an analysis of the pharmaco-
kinetic parameters. The results of the present study
indicated  that  monoclonal  DNP-specific  rat  IgE
administered to rats was distributed to the extrava-
scular compartment early in the experimental period
irrespective  of  the  sensitized  state  based  on  an
analysis of the pharmacokinetic parameters, i.e. the
intercompartmental rate constants (Kct and Ktc) and
distribution  volumes  (Vc and  Vt).  Although  it
remains to be clarified in which tissues the distribu-
tion of IgE was increased, the inference is that the
short half-life of rat IgE could be attributable to the
distribution of IgE from the intravascular to extrava-
scular compartment. The mechanism of IgE catabol-
ism  in  the  intravascular  and/or  extravascular  com-
partment remains unclear. The hypothesis has been
put forward that an increased catabolic rate of IgE is
dependent on the existence of intravascular and/or
extravascular  compartments  capable  of  specifically
clearing  the  IgE.2–4 In  addition,  data  have  been
reported  that  suggested  there  had  been  definite
extravascular catabolism of  IgE,  whereas there  had
been  no significant  extravascular catabolism of  the
other three major immunoglobulin classes (IgG, IgA,
and  IgM).3 It was also  proposed that such extrava-
scular  catabolism could  be  part of an  unique  cata-
bolic mechanism specific for IgE that was related to
unique  interactions of  IgE with basophils and mast
cells.  However,  Isersky  et  al.10 found  no  evidence
for cell-mediated IgE catabolism in their experiments
employing  basophilic  leukemia  cells.  In  addition,
another  report  has  indicated  that  the  clearance  of
passively transferred IgE was not altered by mast cell
deficiency  in  experiments  on  mast  cell-deficient
W/Wv  mice.11 On  the  contrary,  receptor-mediated
endocytosis  of  the  IgE  ligand  has  been  shown  to
ensue  after  binding  monomeric  and  DNP–BSA:IgE
immune  complexes, and the binding  was  inhibited
by anti-CD23.12 It was suggested that normal Fc« RII-
bearing  mature  B  cells  in  the  circulation  and
lymphoid tissues might function in the sequestration
and catabolic turnover of IgE molecules through IgE
or interleukin-4 upregulated Fc« RII uptake. The pres-
ent data and aforementioned reports could thus be
interpreted  to  imply  that  the  turnover  of  IgE  is
related mainly to the interaction of IgE with Fc« RII-
bearing cells in  the extravascular compartment.
Although studies on the relationship between the
catabolic rate of IgE and IgE level in the circulation
K. Hanashiro et al.
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Table 1. Pharmacokinetic parameters for monoclonal DNP-






A (m g/ml) 15.36 ± 7.71 16.42 ± 13.47
B (m g/ml) 1.67 ± 0.97 1.30 ± 0.39
a (/h) 2.12 ± 0.85 1.78 ± 0.26
b (/h) 0.076 ± 0.053 0.063 ± 0.020
Kel (/h) 0.49 ± 0.22 0.52 ± 0.28
Ktc (/h) 6
0.27 ± 0.05 0.26 ± 0.14
Kct (/h) 1.45 ± 0.85* 1.63 ± 0.82*
Vc (/kg) 6
0.57 ± 0.29 0.75 ± 0.69
Vt (/kg) 3.47 ± 2.75** 3.38 ± 0.90***
t1/2a (h) 0.35 ± 0.12 0.40 ± 0.06
t1/2b (h) 13.06 ± 5.66 12.00 ± 3.90
CLtotal (ml/h) 247.64 ± 100.76 264.65 ± 138.23
AUC (h/ml) 31.48 ± 15.38 31.43 ± 15.47
Two milligrams of monoclonal DNP-specific rat IgE was administered
to rats via the jugular vein. Data are expressed as means ± SD (n = 5).
AUC, Area under the serum concentration-time  curve; CLtotal, total
body clearance. * p < 0.05, Kct versus Ktc in each group; ** p < 0.05,
*** p < 0.01, Vt versus Vc in each group.have been  described  by  several  investigators,  their
conclusions were manifold. The fractional catabolic
rate in a patient with IgE myeloma was found to be
decreased as  compared with  that in  normal  volun-
teers.4 It  has  been  reported  that  the  fractional
catabolic rate for IgE was significantly less in atopic
patients and in patients with hyperimmunoglobulin
E-recurrent  infection  syndrome  than  in  normal vol-
unteers.2 The data indicated that the fractional cata-
bolic rate of IgE was inversely related to the serum
IgE concentration. In the present study, monoclonal
DNP-specific rat  IgE  was  therefore administered to
rats at day 8 when the OVA-specific IgE levels in the
serum  reached  their  highest  values.  However,  no
significant  differences  in  kinetic  parameters  of  IgE
were  noted  between  the  non-sensitized  and  OVA-
sensitized rats. Similarly, Haba et al.13 demonstrated
that  the  rates  of  clearance  of  inoculated  IgE  were
approximately  the  same  in  mice  bearing  an  IgE-
secreting  tumor  and  normal  mice.  In  contrast, the
IgE in trypanosome-infected cattle is known to have
greatly  increased catabolic rates as  compared  with
that  of  normal  uninfected  cattle.14 Persistent  high
IgE levels are commonly observed for longer periods
in  patients  with  allergic  diseases  than  in  animal
models.  It  is  suggested  therefore  from  our  results
and  the  aforementioned  reports  that  the  catabolic
rate of IgE is dependent not only on the IgE level in
the  circulating  blood,  but  also  on  differences  in
the  development  of  Fc« receptor-bearing  cells,
based  on  the  duration  of  high  IgE  levels  and  the
course,  duration  and/or  pathway  of  sensitization
with allergen.
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